Allogeneic bone marrow transplantation in Japan

S. Okamoto, S. Asano, H. Shibata, Y. Kodera, T. Masaoka

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Allogeneic bone marrow transplantation (BMT) is being used increasingly to treat diverse diseases in Japan. The distinctive aspects of allogeneic BMT in Japan include the lower incidence of acute graft-versus-host disease, which may be attributable to less disparity in histocompatibility antigens in Japanese. Research in the field of allogeneic BMT in Japan has covered the use of recombinant hemopoietic growth factors, especially granulocyte colony-stimulating factor, and novel immunosuppressive agents.

Original languageEnglish
Pages (from-to)741-742
Number of pages2
JournalBone Marrow Transplantation
Issue number6
Publication statusPublished - 1994
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Allogeneic bone marrow transplantation in Japan'. Together they form a unique fingerprint.

Cite this